Toripalimab (anti-PD-1) versus high-dose interferon-a2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial B. Lian1, L. Si1, Z. H. Chi1, X. N. Sheng1, Y. Kong1, X. Wang1, H. Tian1, K. Li2, L. L. Mao1, X. Bai1, B. X. Tang1, X. Q. Yan1, S. M. Li1, L. Zhou1, J. Dai1, X. W. Tang3, F. W. Ran3, S. Yao3, J. Guo1 & C. L. Cui1*,Annal of Oncology,Volume 33 - Issue 10 - 2022

OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study,JITC,10(4):e004307

An Evidence-Based Staging System for Mucosal Melanoma: A Proposal,Annals of Surgical Oncology,10.1245/s10434-022-11670-6

Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial Xuan Wang 1, Xiaowen Wu 1, Yue Yang, Weiran Xu, Hui Tian, Bin Lian, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Li Zhou, Lili Mao, Siming Li, Bixia Tang, Xieqiao Yan, Xue Bai, Jun Guo, ChuanLiang Cui*,European Journal of Cancer,182 (2023) 57e65

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study Chuanliang Cui1#, Yu Chen2#, Zhiguo Luo3, Zhengyun Zou4, Yu Jiang5, Hongming Pan6, Qingxia Fan7, Jianfu Zhao8, Qing Xu9, Renbing Jiang10, Xuan Wang1, Taiyang Ma11, Zhen Guo12, Lu Si1, Zhihong Chi1, Xinan Sheng1, Yiwei Dou11, Qian Tan11, Di Wu12* and Jun Guo1*,BMC Cancer,(2023) 23:121

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study Li Zhou1#, Xiaowen Wu1#, Zhihong Chi1, Lu Si1, Xinan Sheng1, Yan Kong1, Lili Mao1, Bin Lian1, Bixia Tang1, Xieqiao Yan1, Xuan Wang1, Xue Bai1, Siming Li1, Xiaoting Wei1, Juan Li1, Qing Yang2, Jun Guo1* and Chuanliang Cui1*,BMC Cancer,(2022) 22:565

The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies,Front Oncol,10:546604

Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy Li Zhou 1 , Yue Yang, Lu Si, Zhihong Chi, Xinan Sheng, Bin Lian, Xuan Wang, Bixia Tang, Lili Mao, Xieqiao Yan, Siming Li, Xue Bai, Jun Guo, Chuanliang Cui*,Melanoma Research,2022 Jun 1;32(3):142-149.

CSCO中国黑色素瘤诊治指南, 参编, 人民卫生出版社, 2020.1

CSCO中国黑色素瘤诊治指南, 参编, 人民卫生出版社, 2021.1

CSCO中国尿路上皮癌诊治指南, 参编, 人民卫生出版社, 2020.1

CSCO中国尿路上皮癌诊治指南, 参编, 人民卫生出版社, 2021.1

黑色素瘤；泌尿系肿瘤

嵌入式临床辅助决策系统 V1.0, 实用新型, 第4完成人, 中华人民共和国国家版权局, 中国, 2021.9

免疫联合靶向术前治疗对早期黏膜黑色素瘤免疫微环境的影响及其临床评价, 课题负责人, 2021.1.1～2023.12.1, 北京市医院管理中心

可无创实时动态监测循环肿瘤细胞的多模态在体流式图像 细胞仪, 参加者, 2021.1.1～2025.12.1, 国家自然科学基金委员会

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2025	肿瘤内科学	硕士	专业学位	临床技能训练与研究	全国统考